Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014

  • May 2014
  • -
  • Global Markets Direct
  • -
  • 33 pages

Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Northwest Biotherapeutics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Northwest Biotherapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Northwest Biotherapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Northwest Biotherapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Northwest Biotherapeutics, Inc.’s pipeline products

Reasons to buy

- Evaluate Northwest Biotherapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Northwest Biotherapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Northwest Biotherapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Northwest Biotherapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northwest Biotherapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Northwest Biotherapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Northwest Biotherapeutics, Inc. Snapshot 4
Northwest Biotherapeutics, Inc. Overview 4
Key Information 4
Key Facts 4
Northwest Biotherapeutics, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Northwest Biotherapeutics, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Northwest Biotherapeutics, Inc. - Pipeline Products Glance 9
Northwest Biotherapeutics, Inc. - Late Stage Pipeline Products 9
Phase III Products/Combination Treatment Modalities 9
Northwest Biotherapeutics, Inc. - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Northwest Biotherapeutics, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Northwest Biotherapeutics, Inc. - Drug Profiles 12
DCVax-L Vaccine 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
DCVax-Prostate 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
DCVax-Direct 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
CXCR4 Antibody 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Northwest Biotherapeutics, Inc. - Pipeline Analysis 17
Northwest Biotherapeutics, Inc. - Pipeline Products by Target 17
Northwest Biotherapeutics, Inc. - Pipeline Products by Route of Administration 18
Northwest Biotherapeutics, Inc. - Pipeline Products by Molecule Type 19
Northwest Biotherapeutics, Inc. - Pipeline Products by Mechanism of Action 20
Northwest Biotherapeutics, Inc. - Recent Pipeline Updates 21
Northwest Biotherapeutics, Inc. - Company Statement 28
Northwest Biotherapeutics, Inc. - Locations And Subsidiaries 31
Head Office 31
Other Locations and Subsidiaries 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33

List of Tables

Northwest Biotherapeutics, Inc., Key Information 4
Northwest Biotherapeutics, Inc., Key Facts 4
Northwest Biotherapeutics, Inc. - Pipeline by Indication, 2014 6
Northwest Biotherapeutics, Inc. - Pipeline by Stage of Development, 2014 7
Northwest Biotherapeutics, Inc. - Monotherapy Products in Pipeline, 2014 8
Northwest Biotherapeutics, Inc. - Phase III, 2014 9
Northwest Biotherapeutics, Inc. - Phase I, 2014 10
Northwest Biotherapeutics, Inc. - Preclinical, 2014 11
Northwest Biotherapeutics, Inc. - Pipeline by Target, 2014 17
Northwest Biotherapeutics, Inc. - Pipeline by Route of Administration, 2014 18
Northwest Biotherapeutics, Inc. - Pipeline by Molecule Type, 2014 19
Northwest Biotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 20
Northwest Biotherapeutics, Inc. - Recent Pipeline Updates, 2014 21
Northwest Biotherapeutics, Inc., Subsidiaries 31

List of Figures

Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Indication, 2014 6
Northwest Biotherapeutics, Inc. - Pipeline by Stage of Development, 2014 7
Northwest Biotherapeutics, Inc. - Monotherapy Products in Pipeline, 2014 8
Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Target, 2014 17
Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2014 18
Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2014 19

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Alethia Biotherapeutics Inc. - Product Pipeline Review - 2015

Alethia Biotherapeutics Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Alethia Biotherapeutics Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Alethia Biotherapeutics Inc. - Product Pipeline Review - 2015’, provides an overview of the Alethia ...

Aeglea BioTherapeutics Holdings, LLC - Product Pipeline Review - 2015

Aeglea BioTherapeutics Holdings, LLC - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Aeglea BioTherapeutics Holdings, LLC - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Aeglea BioTherapeutics Holdings, LLC - Product Pipeline Review - 2015’, provides an overview ...

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2015
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company. The company’s product includes taliglucerase alfa or alfataliglicerase which is a plant cell, expressed form of the ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.